Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 1997

View Archived Issues

Annual Report: Peptech

MedImmune reports product sales increase 250% for Q4 1996

Cortex fiscal 1997 second-quarter and six-month results

Lidak announces first-quarter fiscal 1997 financial results

AEterna's 1996 financial results

Sugen continues to focus on TK inhibitors

Gliatech prepares H3 agonists

Antiproliferative agents from Pfizer

U.S. researchers prepare chloroquine analogues

Agents for BPH disclosed by Merck & Co.

SKB prepares cytokine inhibitors

University of California researchers report pseudopterosin derivatives

Antiarrhythmic agents from Merck & Co.

GRC-active agents from CoCensys modulate brain excitability

Another launch for SKB vaccine

Antiacne treatment available in the U.K.

First launch for lipid-lowering statin

Astra anesthetic/analgesic introduced in the U.K.

U.K. launch for P&U glaucoma Rx

New paclitaxel combination demonstrates enhanced efficacy

Efficacy of leukotriene antagonist in asthma

Role of bFGF in gastric ulcer healing

New ACAT inhibitor associated with diarrhea

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...